2016 American Transplant Congress » Concurrent Session: Kidney: Induction Therapy 2

Date: Tuesday, June 14, 2016

Time: 4:30pm-6:00pm

Location: Room 312

Session Type: Concurrent Session

Meeting: 2016 American Transplant Congress

4:30pm-4:42pm: The Impact of Ritonavir-Boosted Protease Inhibitors and Non-Depleting Antibody Induction on Outcomes in HIV-Infected Kidney Transplant Recipients.

B. Rollins, S. Lerner, M. Rana, S. Huprikar, L. Miko, V. Nair, S. Florman, R. Shapiro.

4:42pm-4:54pm: Induction Therapy with Depleting Antibodies in Low Immunological Risk Renal Transplant Patients Treated with a Steroid Free Regimen – Comparison of Alemtuzumab vs. Antithymocyte Globulin.

N. Bossini,¹ S. Sandrini,¹ R. Tardanico,² F. Valerio,¹ G. Setti,¹ C. Salviani,¹ S. Possenti,¹ P. Foini,¹ E. Marta,¹ G. Cancarini.¹

4:54pm-5:06pm: Associations of Risk Factors and Kidney Retransplant Outcomes Vary Between Three Common Induction Agents: Results from the Analysis of Over Ten-Thousand Cases in Ten Years.

A. Santos, X. Wen, M. Casey, S. Rehman, K. Womer.

5:06pm-5:18pm: Outcomes of Depleting Antibody Induction in Kidney Transplantation: A Paired Kidney Analysis.

M. Sampaio, B. Chopra, K. Sureshkumar.

5:18pm-5:30pm: Induction Immunosuppression and Post-Transplant Outcomes in Kidney Recipients with Hepatitis C Virus.

S. Bae, C. Durand, L. Kucirka, A. Massie, D. Segev.

5:30pm-5:42pm: Tailored Rabbit Anti-Thymocyte Globulin Induction (rATG) Dosing for Kidney Transplantation.

N. Singh,^1,2 A. Rossi,¹ M. Savic,¹ R. Rubocki,¹ M. Parker,¹ J. Vella.¹

5:42pm-5:54pm: Antithymocyte Globulin (ATG) versus Anti-interleukin-2 Receptor (Anti-IL-2R) as Induction Therapy for Kidney Transplantation After a Nonrenal Transplant.

H. Mai,¹ K. Trébern-Launay,¹ C. Legendre,² M. Kessler,³ L. Rostaing,⁴ V. Garrigue,⁵ E. Morelon,⁶ S. Brouard,¹ M. Giral,¹ J.-P. Soulillou.¹

« View all sessions from the 2016 American Transplant Congress